Citigroup reissued an outperform rating for DBV Technologies.
6 reports, 3 independent
Updated Oct 14
Gone quiet
- Reports
- 6
- Developments
- 1
- Repetition
- 83%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Citigroup reissued an outperform rating for DBV Technologies.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Citigroup
American investment bank and financial services corporation
-
DBV Technologies
publicly owned French biopharmaceutical firm headquartered in Bagneux, France
Related events
- Citigroup reissued a market outperform rating for Applied Digital Corporation on October 15, 2026.
- Citigroup reaffirmed a market outperform rating for HealthEquity.
- Citigroup reissued a market outperform rating for Sphere Entertainment Co. stock.
- Citigroup reiterated a market outperform rating for Alphabet Inc.
- Citigroup reissued a market outperform rating and Leerink Partners began coverage on Rapport Therapeutics.